Stocktoria

CRYO CELL INTERNATIONAL INC CCEL

NYSE · stock · Services-Misc Health & Allied Services, NEC · website · IPO 1994-04-04 · LEI

CRYO CELL INTERNATIONAL INC statistics & valuation

Market cap$26.7M
P / S0.8×
P / FCF5.1×
Dividend yield12.08%
Net margin-7.7%
FCF margin16.6%
Net debt$8.0M
Net debt / EBITDA5.5×
Enterprise value USD$34.8M
EV / EBITDA23.7×
Earnings yield EBIT/EV1.4%
Return on capital1.2%

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-5.70% 9.10% -2.90% 7.20% 11.60% 7.20% 9.10% -30.40% 1.30% -7.70% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
1.90% 19.70% 17.80% 15.90% 24.60% 13.90% 13.30% -39.30% 10.90% 1.50% 2016201720182019202020212022202320242025
Return on equity (%)
49.80% 2016201720182019202020212022202320242025
Shares outstanding
8.1M 7.7M 7.8M 8.4M 8.1M 8.6M 8.5M 8.3M 8.2M 8.1M 2016201720182019202020212022202320242025
Net debt ($)
$6.3M $1.0M $6.9M $2.4M -$4.4M -$6.4M $7.0M $8.2M $7.9M $8.0M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-6.80% 9.70% -2.00% 5.30% 7.80% 3.40% 4.30% -14.70% 0.60% -3.90% 2016201720182019202020212022202320242025
Free cash flow margin (%)
20.10% 22.10% 16.70% 17.70% 26.90% 21.10% -11.90% 6.60% 11.30% 16.60% 2016201720182019202020212022202320242025
Debt / equity (×)
0.45× 2016201720182019202020212022202320242025
EPS ($)
-$0.16 $0.30 -$0.11 $0.27 $0.45 $0.25 $0.33 -$1.14 $0.05 -$0.30 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

CRYO CELL INTERNATIONAL INC trades at about 84.8× earnings — above its 10-year norm (10-year range 3.9×–148.2×, median 32.2×).

3.9× 148.2×

Shaded band = 10-year range (3.9×–148.2×); dot = today's 84.8×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin1.5%10.9%-39.3%13.3%13.9%24.6%15.9%17.8%19.7%1.9%
Net margin-7.7%1.3%-30.4%9.1%7.2%11.6%7.2%-2.9%9.1%-5.7%
FCF margin16.6%11.3%6.6%-11.9%21.1%26.9%17.7%16.7%22.1%20.1%
Return on assets-3.9%0.6%-14.7%4.3%3.4%7.8%5.3%-2.0%9.7%-6.8%
Return on equity13.1%-3.0%86.3%-181.8%49.8%-136.0%-32.9%9.6%-18.5%8.6%
Debt / equity-0.45×-0.64×-0.78×-5.73×0.45×-2.23×-1.29×-1.45×-0.58×-0.64×
Current ratio0.590.580.450.490.751.131.000.960.910.69

Computed from company filings · US · as of 2025-11-30. Facts plus Stocktoria's own computed scores — not investment advice.